HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9.

Abstract
Neuronal homeostasis and survival critically depend on an efficient autophagy-lysosomal degradation pathway, especially since neurons cannot reduce the concentration of misfolded proteins and damaged organelles by cell division. While increasing evidence implicates lysosomal dysfunction in the pathogenesis of neurodegenerative disorders, the molecular underpinnings of the role of lysosomes in neurodegeneration remain largely unknown. To this end, studies of neurodegenerative disorders caused by mutations in lysosomal proteins offer an opportunity to elucidate such mechanisms and potentially identify specific therapeutic targets. One of these disorders is Kufor-Rakeb syndrome, caused by mutations in the lysosomal protein ATP13A2/PARK9 and characterized by early-onset Parkinsonism, pyramidal degeneration and dementia. We found that loss of ATP13A2 function results in impaired lysosomal function and, consequently, accumulation of SNCA/α-synuclein and neurotoxicity. Our results suggest that targeting of ATP13A2 to lysosomes to enhance lysosomal function may result in neuroprotection in Kufor-Rakeb syndrome. From a broader perspective, these findings, together with other recent studies of lysosomal dysfunction in neurodegeneration, suggest that strategies to upregulate lysosomal function in neurons represent a promising therapeutic approach for neurodegenerative disorders.
AuthorsMarija Usenovic, Dimitri Krainc
JournalAutophagy (Autophagy) Vol. 8 Issue 6 Pg. 987-8 (Jun 2012) ISSN: 1554-8635 [Electronic] United States
PMID22561922 (Publication Type: Journal Article)
Chemical References
  • alpha-Synuclein
  • Glucosylceramidase
  • Proton-Translocating ATPases
Topics
  • Animals
  • Caenorhabditis elegans (metabolism)
  • Glucosylceramidase (metabolism)
  • Humans
  • Lysosomes (metabolism)
  • Mice
  • Nerve Degeneration (enzymology, physiopathology)
  • Proton-Translocating ATPases (metabolism)
  • alpha-Synuclein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: